APA (7th ed.) Citation

Sadremomtaz, A., Mansouri, K., Alemzadeh, G., Safa, M., Rastaghi, A. E., & Asghari, S. M. (2018). Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway. Biochimica et biophysica acta. General subjects, 1862(12), 2688-2700. https://doi.org/10.1016/j.bbagen.2018.08.013

Chicago Style (17th ed.) Citation

Sadremomtaz, Afsaneh, Kamran Mansouri, Golnaz Alemzadeh, Majid Safa, Ahmadreza Esmaeili Rastaghi, and S. Mohsen Asghari. "Dual Blockade of VEGFR1 and VEGFR2 by a Novel Peptide Abrogates VEGF-driven Angiogenesis, Tumor Growth, and Metastasis Through PI3K/AKT and MAPK/ERK1/2 Pathway." Biochimica Et Biophysica Acta. General Subjects 1862, no. 12 (2018): 2688-2700. https://doi.org/10.1016/j.bbagen.2018.08.013.

MLA (9th ed.) Citation

Sadremomtaz, Afsaneh, et al. "Dual Blockade of VEGFR1 and VEGFR2 by a Novel Peptide Abrogates VEGF-driven Angiogenesis, Tumor Growth, and Metastasis Through PI3K/AKT and MAPK/ERK1/2 Pathway." Biochimica Et Biophysica Acta. General Subjects, vol. 1862, no. 12, 2018, pp. 2688-2700, https://doi.org/10.1016/j.bbagen.2018.08.013.